Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback